FOR PATIENTS · SOURCE READING
Targeted therapy
Source: Acute Myeloid Leukemia Treatment (PDQ®)–Patient Version, National Cancer Institute.
Source updated: May 16, 2025 · Captured 2026-09-09.
Selected source text with whitespace normalised. This Triangle page is not an NCI PDQ summary. Independent clinical review is pending.
Context: Treatment Option Overview / The following types of treatment are used:
Targeted therapy uses drugs or other substances to identify and attack specific cancer cells. Your doctor may suggest biomarker tests to help predict your response to certain targeted therapy drugs. Learn more about Biomarker Testing for Cancer Treatment.
Source links and citations
Targeted therapies used to treat AML include:
gemtuzumab ozogamicin
Source links and citations
midostaurin
Source links and citations
quizartinib
Source links and citations
revumenib
Source links and citations
Less-intensive targeted therapies in people who are unable or unwilling to receive other treatments include:
enasidenib
Source links and citations
gilteritinib
Source links and citations
glasdegib
Source links and citations
ivosidenib
Source links and citations
venetoclax
Source links and citations
Learn more about Targeted Therapy to Treat Cancer.
Source links and citations
Preserved source evidence · Independent clinical review pending · Not medical advice
Triangle